Healthcare Sales & Marketing Network News: reSept ASD Occluder

Searching News Database: reSept ASD Occluder

HSMN NewsFeed - 8 Feb 2022
atHeart Medical Receives FDA Approval for the Second Phase of the ASCENT ASD U.S. IDE Trial
Devices Interventional Cardiology FDA

HSMN NewsFeed - 8 Sep 2021
atHeart Medical Appoints Seasoned Medtech Executive Andrew Cleeland to Board of Directors
Devices Cardiology Personnel

HSMN NewsFeed - 14 Jul 2021
First Five Patients Successfully Treated with atHeart Medical's Novel reSept(TM) Atrial Septal Defect Occluder in U.S. IDE Pivotal Trial
Devices Interventional Cardiology

HSMN NewsFeed - 20 Apr 2021
Newly Formed Company, atHeart Medical, Aims to Evolve Septal Closure with the reSept(TM) ASD Occluder
Devices Interventional Cardiology

Return to NewsFeed

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.